Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO)

CUSIP: 589492107

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Ordinary Shares, par value GBP 0.003 per share
Shares outstanding
792,553,191
Total 13F shares
63,630,062
Share change
+2,838,735
Total reported value
$83,982,713
Put/Call ratio
7.2%
Price per share
$1.32
Number of holders
48
Value change
+$9,810,717
Number of buys
14
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 589492107?
CUSIP 589492107 identifies MREO - Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) as of Q2 2023

As of 30 Jun 2023, Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 63,630,062 shares. The largest 10 holders included Rubric Capital Management LP, SUVRETTA CAPITAL MANAGEMENT, LLC, Rock Springs Capital Management LP, MANGROVE PARTNERS, 683 Capital Management, LLC, ALKEON CAPITAL MANAGEMENT LLC, BAKER BROS. ADVISORS LP, Tejara Capital Ltd, Boxer Capital, LLC, and GOLDMAN SACHS GROUP INC. This page lists 48 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.